An Exciting Time for Mass Spec: Paul Beresford, Biodesix
Jan 15, 2015•20 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Guest:
Paul Beresford, VP of Bus Dev, Biodesix
Bio and Contact Info
Listen (4:47) VeriStrat - a test for non-small cell lung cancer
Listen (4:39) What do you anticipate on the regulatory front?
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Paul Beresford, VP of Bus Dev, Biodesix
Bio and Contact Info
Listen (4:47) VeriStrat - a test for non-small cell lung cancer
Listen (4:39) What do you anticipate on the regulatory front?
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
For the best experience, listen in Metacast app for iOS or Android